
|Slideshows|June 22, 2017
Update on Migraine and Parkinson Disease: 3 New Studies
Author(s)Mark L. Fuerst
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-IL6R Therapy Effective in Reducing NMOSD and MOGAD Disease Activity
2
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia
3
Phase 3 EMBARK Data Released, CTE Associated with Dementia Risk, Pilavapadin Heads to Phase 3 Pain Studies
4
NeurologyLive® Brain Games: February 1, 2025
5











